Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onur Ural

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
BMC Infectious Diseases|December 5, 2024
Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter studyYakup Gezer, Muhammet Rıdvan Tayşi, Arzu Tarakçı, et al.
BMC Infectious Diseases|December 16, 2024
Correction: Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter studyYakup Gezer, Muhammet Rıdvan Tayşi, Arzu Tarakçı, et al.
International Journal of Psychiatry in Medicine|December 28, 2020
Evaluation of the relationship between perceived social support, coping strategies, anxiety, and depression symptoms among hospitalized COVID-19 patientsAli Kandeğer, Memduha Aydın, Kürşat Altınbaş, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 13, 2016
Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis CElif Sargin Altunok, Murat Sayan, Sila Akhan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 16, 2020
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experienceBilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, et al.
Infectious Diseases & Clinical Microbiology|January 19, 2026
Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting MortalityNazlım Aktuğ Demir, Fatih Temoçin, Onur Ural, et al.
Balkan Medical Journal|March 12, 2016
Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective StudyYunus Gürbüz, Necla Eren Tülek, Emin Ediz Tütüncü, et al.
Journal of Infection in Developing Countries|April 18, 2024
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in TurkeyMustafa K Çelen, Buket Ertürk Şengel, Şafak Kaya, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 7, 2021
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?Neşe Demirtürk, Bilgehan Aygen, İlhami Çelik, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2026
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infectionsAbdullah T Aslan, Yukiko Ezure, Elif Seren Tanriverdi, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
BMC Infectious Diseases|December 5, 2024
Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter studyYakup Gezer, Muhammet Rıdvan Tayşi, Arzu Tarakçı, et al.
BMC Infectious Diseases|December 16, 2024
Correction: Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter studyYakup Gezer, Muhammet Rıdvan Tayşi, Arzu Tarakçı, et al.
International Journal of Psychiatry in Medicine|December 28, 2020
Evaluation of the relationship between perceived social support, coping strategies, anxiety, and depression symptoms among hospitalized COVID-19 patientsAli Kandeğer, Memduha Aydın, Kürşat Altınbaş, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 13, 2016
Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis CElif Sargin Altunok, Murat Sayan, Sila Akhan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 16, 2020
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experienceBilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, et al.
Infectious Diseases & Clinical Microbiology|January 19, 2026
Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting MortalityNazlım Aktuğ Demir, Fatih Temoçin, Onur Ural, et al.
Balkan Medical Journal|March 12, 2016
Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective StudyYunus Gürbüz, Necla Eren Tülek, Emin Ediz Tütüncü, et al.
Journal of Infection in Developing Countries|April 18, 2024
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in TurkeyMustafa K Çelen, Buket Ertürk Şengel, Şafak Kaya, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 7, 2021
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?Neşe Demirtürk, Bilgehan Aygen, İlhami Çelik, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2026
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infectionsAbdullah T Aslan, Yukiko Ezure, Elif Seren Tanriverdi, et al.
Pageof 4